Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Savage

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Current Opinion in Lipidology|May 29, 2019
Recent developments in lipodystrophyAudrey Melvin, Anna Stears, David B Savage
Endocrine Development|February 9, 2013
Human congenital perilipin deficiency and insulin resistanceKristina Kozusko, Satish Patel, David B Savage
The New England Journal of Medicine|January 6, 2010
Sex hormone-binding globulin and risk of type 2 diabetesRobert Semple, David B Savage, Steven O'Rahilly
International Journal of Dermatology|October 31, 2013
Acquired generalized lipodystrophy associated with peripheral T cell lymphoma with cutaneous infiltrationArif Aslam, David B Savage, Ian H Coulson
Current Opinion in Cell Biology|May 20, 2015
Lipid droplet-organelle interactions: emerging roles in lipid metabolismAntonio Daniel Barbosa, David B Savage, Symeon Siniossoglou
Hypertension (Dallas, Tex. : 1979)|April 13, 2005
Mechanisms of insulin resistance in humans and possible links with inflammationDavid B Savage, Kitt F Petersen, Gerald I Shulman
Physiological Reviews|April 13, 2007
Disordered lipid metabolism and the pathogenesis of insulin resistanceDavid B Savage, Kitt Falk Petersen, Gerald I Shulman
Best Practice & Research. Clinical Endocrinology & Metabolism|April 14, 2012
Metabolic insights from extreme human insulin resistance phenotypesAnna Stears, Stephen O'Rahilly, Robert K Semple, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophyDavid B Savage, Peter R Murgatroyd, V Krishna Chatterjee, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulationMark Gurnell, David B Savage, V Krishna K Chatterjee, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Current Opinion in Lipidology|May 29, 2019
Recent developments in lipodystrophyAudrey Melvin, Anna Stears, David B Savage
Endocrine Development|February 9, 2013
Human congenital perilipin deficiency and insulin resistanceKristina Kozusko, Satish Patel, David B Savage
The New England Journal of Medicine|January 6, 2010
Sex hormone-binding globulin and risk of type 2 diabetesRobert Semple, David B Savage, Steven O'Rahilly
International Journal of Dermatology|October 31, 2013
Acquired generalized lipodystrophy associated with peripheral T cell lymphoma with cutaneous infiltrationArif Aslam, David B Savage, Ian H Coulson
Current Opinion in Cell Biology|May 20, 2015
Lipid droplet-organelle interactions: emerging roles in lipid metabolismAntonio Daniel Barbosa, David B Savage, Symeon Siniossoglou
Hypertension (Dallas, Tex. : 1979)|April 13, 2005
Mechanisms of insulin resistance in humans and possible links with inflammationDavid B Savage, Kitt F Petersen, Gerald I Shulman
Physiological Reviews|April 13, 2007
Disordered lipid metabolism and the pathogenesis of insulin resistanceDavid B Savage, Kitt Falk Petersen, Gerald I Shulman
Best Practice & Research. Clinical Endocrinology & Metabolism|April 14, 2012
Metabolic insights from extreme human insulin resistance phenotypesAnna Stears, Stephen O'Rahilly, Robert K Semple, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophyDavid B Savage, Peter R Murgatroyd, V Krishna Chatterjee, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulationMark Gurnell, David B Savage, V Krishna K Chatterjee, et al.
Pageof 12